Cerebrolysin
A neuropeptide preparation studied for neuroprotection, cognitive function, and recovery after brain injury.
GDNF is a neurotrophic factor known for its ability to support and regenerate dopaminergic neurons. It is a significant focus in research for conditions involving neurodegeneration.
In the literature, GDNF appears most often in work focused on neuroprotection, brain health and nerve pain. Studies in this area tend to look at mechanisms and observed effects in laboratory and preclinical settings rather than outcomes in people, so the picture is best read as a map of where researchers have been curious — not as evidence of any benefit.
Because it is catalogued here under powder peptides, GDNF also shows up in discussions of cellular repair. Coverage across those topics varies widely in quality and depth, and much of it is early-stage. Reading the underlying research directly is the only way to judge how strong any particular finding is.
Tap a topic to see which peptides are most studied for it.
A neuropeptide preparation studied for neuroprotection, cognitive function, and recovery after brain injury.
Angiotensin IV is a metabolite of the renin-angiotensin system primarily studied for its cognitive-enhancing properties. Researchers investigate its role in memory consolidation and retrieval, without significant cardiovascular effects.
An EPO-derived peptide studied for neuropathic pain, small fiber neuropathy, and tissue protection.
Research use only. This page summarizes areas of published study and is not medical advice. No dosing, protocol, or usage guidance is provided.